These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26572803)

  • 1. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
    Hall BS; Hill K; McKenna M; Ogbechi J; High S; Willis AE; Simmonds RE
    PLoS Pathog; 2014 Apr; 10(4):e1004061. PubMed ID: 24699819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease.
    Demangel C; High S
    Biol Cell; 2018 Nov; 110(11):237-248. PubMed ID: 30055020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.
    Demangel C; Stinear TP; Cole ST
    Nat Rev Microbiol; 2009 Jan; 7(1):50-60. PubMed ID: 19079352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation.
    Guenin-Macé L; Veyron-Churlet R; Thoulouze MI; Romet-Lemonne G; Hong H; Leadlay PF; Danckaert A; Ruf MT; Mostowy S; Zurzolo C; Bousso P; Chrétien F; Carlier MF; Demangel C
    J Clin Invest; 2013 Apr; 123(4):1501-12. PubMed ID: 23549080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone.
    McKenna M; Simmonds RE; High S
    J Cell Sci; 2016 Apr; 129(7):1404-15. PubMed ID: 26869228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 13. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
    Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
    PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
    Warryn L; Dangy JP; Gersbach P; Gehringer M; Schäfer A; Ruf MT; Ruggli N; Altmann KH; Pluschke G
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008357. PubMed ID: 32589646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
    Hall B; Simmonds R
    Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.
    Bieri R; Scherr N; Ruf MT; Dangy JP; Gersbach P; Gehringer M; Altmann KH; Pluschke G
    ACS Chem Biol; 2017 May; 12(5):1297-1307. PubMed ID: 28294596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans.
    López CA; Unkefer CJ; Swanson BI; Swanson JMJ; Gnanakaran S
    PLoS Comput Biol; 2018 Feb; 14(2):e1005972. PubMed ID: 29401455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity against Mycobacterium ulcerans: The subversive role of mycolactone.
    Demangel C
    Immunol Rev; 2021 May; 301(1):209-221. PubMed ID: 33607704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.